{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:53:32Z","timestamp":1794664412365,"version":"4.9.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Top Talent of Changzhou \u201cThe 14th Five-Year Plan\u201d High-Level Health Talents Training Project","award":["2022CZBJ051"],"award-info":[{"award-number":["2022CZBJ051"]}]},{"name":"the Clinical Research Project of Changzhou Medical Center of Nanjing Medical University","award":["CMCC202309"],"award-info":[{"award-number":["CMCC202309"]}]},{"name":"the Science and Technology Project of Changzhou Health Commission","award":["ZD202336"],"award-info":[{"award-number":["ZD202336"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03879-y","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T16:32:26Z","timestamp":1744993946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of Saccharomyces boulardii supplementation to bismuth quadruple therapy on Helicobacter pylori eradication"],"prefix":"10.1186","volume":"25","author":[{"given":"Yi-Zhou","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo-Ya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"key":"3879_CR1","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1056\/NEJMcp1710945","volume":"380","author":"SE Crowe","year":"2019","unstructured":"Crowe SE. Helicobacter pylori infection. New Engl J Med. 2019;380:1158\u201365. [PMID: 30893536 https:\/\/doi.org\/10.1056\/NEJMcp1710945].","journal-title":"New Engl J Med"},{"key":"3879_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327745","author":"P Malfertheiner","year":"2022","unstructured":"Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, Gasbarrini A, Hunt RH, Leja M, O\u2019Morain C, Rugge M, Suerbaum S, Tilg H, Sugano K, El-Omar EM. Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report. Gut. 2022. [PMID: 35944925 https:\/\/doi.org\/10.1136\/gutjnl-2022-327745].","journal-title":"Gut"},{"key":"3879_CR3","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1097\/CM9.0000000000002546","volume":"135","author":"L Zhou","year":"2022","unstructured":"Zhou L, Lu H, Song Z, Lyu B, Chen Y, Wang J, Xia J, Zhao Z. 2022 Chinese National clinical practice guideline on Helicobacter pylori eradication treatment. Chin Med J-Peking. 2022;135:2899\u2013910. [PMID: 36579940 https:\/\/doi.org\/10.1097\/CM9.0000000000002546].","journal-title":"Chin Med J-Peking"},{"key":"3879_CR4","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","volume":"155","author":"A Savoldi","year":"2018","unstructured":"Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of antibiotic resistance in Helicobacter pylori: A systematic review and Meta-analysis in world health organization regions. Gastroenterology. 2018;155:1372-1382.e17. [PMID: 29990487 https:\/\/doi.org\/10.1053\/j.gastro.2018.07.007].","journal-title":"Gastroenterology"},{"key":"3879_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1159\/000519413","volume":"103","author":"S Suzuki","year":"2022","unstructured":"Suzuki S, Kusano C, Horii T, Ichijima R, Ikehara H. The ideal Helicobacter pylori treatment for the present and the future. Digestion. 2022;103:62\u20138. [PMID: 34662879 https:\/\/doi.org\/10.1159\/000519413].","journal-title":"Digestion"},{"key":"3879_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cgh.2018.09.028]","volume":"17","author":"E Quigley","year":"2019","unstructured":"Quigley E. Prebiotics and probiotics in digestive health. Clin Gastroenterol H. 2019;17:333\u201344. [PMID: 30267869 https:\/\/doi.org\/10.1016\/j.cgh.2018.09.028]]","journal-title":"Clin Gastroenterol H"},{"key":"3879_CR7","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s00284-020-02053-9]","volume":"77","author":"K Kazmierczak-Siedlecka","year":"2020","unstructured":"Kazmierczak-Siedlecka K, Ruszkowski J, Fic M, Folwarski M, Makarewicz W. Saccharomyces boulardii CNCM I-745: A Non-bacterial microorganism used as probiotic agent in supporting treatment of selected diseases. Curr Microbiol. 2020;77:1987\u201396. [PMID: 32472262 https:\/\/doi.org\/10.1007\/s00284-020-02053-9]]","journal-title":"Curr Microbiol"},{"key":"3879_CR8","doi-asserted-by":"publisher","first-page":"32512834","DOI":"10.3390\/jof6020078","volume":"6 PMID","author":"P Pais","year":"2020","unstructured":"Pais P, Almeida V, Yilmaz M, Teixeira MC. Saccharomyces boulardii: what makes it tick as successful probiotic?? J Fungi. 2020;6 PMID:32512834. https:\/\/doi.org\/10.3390\/jof6020078.","journal-title":"J Fungi"},{"key":"3879_CR9","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1365-2036.2010.04457.x]","volume":"32","author":"H Szajewska","year":"2010","unstructured":"Szajewska H, Horvath A, Piwowarczyk A. Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment. Aliment Pharm Ther. 2010;32:1069\u201379. [PMID: 21039671 https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04457.x].","journal-title":"Aliment Pharm Ther"},{"key":"3879_CR10","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/apt.13214","volume":"41","author":"H Szajewska","year":"2015","unstructured":"Szajewska H, Horvath A, Kolodziej M. Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection. Aliment Pharm Ther. 2015;41:1237\u201345. [PMID: 25898944 https:\/\/doi.org\/10.1111\/apt.13214].","journal-title":"Aliment Pharm Ther"},{"key":"3879_CR11","doi-asserted-by":"publisher","first-page":"e12651","DOI":"10.1111\/hel.12651]","volume":"24","author":"BG Zhou","year":"2019","unstructured":"Zhou BG, Chen LX, Li B, Wan LY, Ai YW. Saccharomyces boulardii as an adjuvant therapy for Helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysis. Helicobacter. 2019;24:e12651. [PMID: 31414551 https:\/\/doi.org\/10.1111\/hel.12651]].","journal-title":"Helicobacter"},{"key":"3879_CR12","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928]","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. Bmj-Brit Med J. 2011;343:d5928. [PMID: 22008217 https:\/\/doi.org\/10.1136\/bmj.d5928]].","journal-title":"Bmj-Brit Med J"},{"key":"3879_CR13","doi-asserted-by":"publisher","first-page":"776955","DOI":"10.3389\/fmed.2021.776955]","volume":"8","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Yang Y, Aruna, Xiao J, Song J, Huang T, Li S, Kou J, Huang L, Ji D, Xiong S, Peng W, Xu S, Cheng B. Saccharomyces boulardii combined with quadruple therapy for Helicobacter pylori eradication decreased the duration and severity of diarrhea: A Multi-Center prospective randomized controlled trial. Front Med-Lausanne. 2021;8:776955. [PMID: 34869495 https:\/\/doi.org\/10.3389\/fmed.2021.776955]].","journal-title":"Front Med-Lausanne"},{"key":"3879_CR14","doi-asserted-by":"publisher","unstructured":"He C, Kong F, Chai X, Zou C, Zhu X, Zhao D. Effect of Probiotic-Assisted Eradication of cagA+\/vacA s1m1 Helicobacter pylori on Intestinal Flora. Biomed Res Int 2022; 2022: 8607671 [PMID: 35528160 https:\/\/doi.org\/10.1155\/2022\/8607671]","DOI":"10.1155\/2022\/8607671"},{"key":"3879_CR15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3870\/j.issn.1004-0781.2017.09.009]","volume":"36","author":"SZ Dong","year":"2017","unstructured":"Dong SZ, Liu YT, Zhang JJ, Xin KM, Ren SP. Treatment of quadruple therapy combined with Saccharomyces boulardii sachets on Helicobacter pylori infection: A report of 125 cases. Herald Med. 2017;36:987\u20139. https:\/\/doi.org\/10.3870\/j.issn.1004-0781.2017.09.009].","journal-title":"Herald Med"},{"key":"3879_CR16","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.3760\/cma.j.issn.0376-2491.2017.30.008]","volume":"97","author":"XY Zhu","year":"2017","unstructured":"Zhu XY, Du J, Wu J, Zhao LW, Meng X, Liu GF. Influence of Saccharomyces boulardii sachets combined with bismuth quadruple therapy for initial Helicobacter pylori eradication. Natl Med J China. 2017;97:2353\u20136. [PMID: 28822453 https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2017.30.008]].","journal-title":"Natl Med J China"},{"key":"3879_CR17","first-page":"3040","volume":"27","author":"WJ Du","year":"2018","unstructured":"Du WJ, Zhang YN, Zheng YJ. Efficacy of Saccharomyces boulardii in combination with quadruple therapy for Helicobacter Pylori eradication. Henan Med Res. 2018;27:3040\u20131.","journal-title":"Henan Med Res"},{"key":"3879_CR18","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.3760\/cma.j.issn.0376-2491.2018.28.007]","volume":"98","author":"XY Zhu","year":"2018","unstructured":"Zhu XY, Du J, Zhao WJ, Wu J, Zhao LW, Meng X, Yang L, Jiao L, Ma H. Influence of two kinds of probiotics combined with bismuth quadruple therapy for Helicobacter pylori eradication. Natl Med J China. 2018;98:2246\u20139. [PMID: 30078279 https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2018.28.007]].","journal-title":"Natl Med J China"},{"key":"3879_CR19","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.3760\/cma.j.issn.0376-2491.2019.22.010]","volume":"99","author":"CX He","year":"2019","unstructured":"He CX, Kong FT, Liang F, Wang KX, Li H, Liu YL, Zhao W, Zhou PP, Kong FL. Influence of different timing of Saccharomyces boulardii combined with bismuth quadruple therapy for Helicobacter pylori eradication. Natl Med J China. 2019;99:1731\u20134. [PMID: 31216821 https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2019.22.010]]","journal-title":"Natl Med J China"},{"key":"3879_CR20","first-page":"519","volume":"37","author":"HB Zhao","year":"2013","unstructured":"Zhao HB, Chen XQ, Zhou L. The effect of Saccharomyces boulardii combined with standard quadruple therapy. Guizhou Med J. 2013;37:519\u201321.","journal-title":"Guizhou Med J"},{"key":"3879_CR21","doi-asserted-by":"publisher","first-page":"175628482211477","DOI":"10.1177\/17562848221147763]","volume":"16","author":"XJ He","year":"2023","unstructured":"He XJ, Wang XL, Sun DJ, Huang XY, Liu G, Li DZ, Lin HL, Zeng XP, Li DL, Wang W. The efficacy and safety of Saccharomyces boulardii in addition to antofloxacin-based bismuth quadruple therapy for Helicobacter pylori eradication: a single-center, prospective randomized-control study. Ther Adv Gastroenter. 2023;16:17562848221147763. [PMID: 36742013 https:\/\/doi.org\/10.1177\/17562848221147763]]","journal-title":"Ther Adv Gastroenter"},{"key":"3879_CR22","first-page":"58","volume":"16","author":"YY Chen","year":"2023","unstructured":"Chen YY, Feng P, Wu SB. Efficacy and safety of Saccharomyces boulardii combined with esomeprazole-contained quadruple therapy for Helicobacter pylori eradication. Chin J Clin Rational Drug Use. 2023;16:58\u201362.","journal-title":"Chin J Clin Rational Drug Use"},{"key":"3879_CR23","doi-asserted-by":"publisher","unstructured":"Sakarya S, Gunay N. Saccharomyces boulardii expresses neuraminidase activity selective for alpha2,3-linked Sialic acid that decreases Helicobacter pylori adhesion to host cells. Apmis. 2014;122. 941\u201350 [PMID: 24628732 https:\/\/doi.org\/10.1111\/apm.12237]","DOI":"10.1111\/apm.12237"},{"key":"3879_CR24","doi-asserted-by":"publisher","unstructured":"Dahan S, Dalmasso G, Imbert V, Peyron JF, Rampal P, Czerucka D. Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infect Immun. 2003;71. 766\u201373. [PMID: 12540556 https:\/\/doi.org\/10.1128\/IAI.71.2.766-773.2003]","DOI":"10.1128\/IAI.71.2.766-773.2003"},{"key":"3879_CR25","doi-asserted-by":"publisher","unstructured":"Song MJ, Park DI, Park JH, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI. The effect of probiotics and mucoprotective agents on PPI-based triple therapy for eradication of Helicobacter pylori. Helicobacter. 2010;15. 206\u2013\u200913. [PMID: 20557362 https:\/\/doi.org\/10.1111\/j.1523-5378.2010.00751.x].","DOI":"10.1111\/j.1523-5378.2010.00751.x"},{"key":"3879_CR26","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/j.1365-2036.2007.03442.x","volume":"26","author":"D Czerucka","year":"2007","unstructured":"Czerucka D, Piche T, Rampal P. Review Article: yeast as probiotics -- Saccharomyces boulardii. Aliment Pharm Ther. 2007;26:767\u201378. [PMID: 17767461 https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03442.x].","journal-title":"Aliment Pharm Ther"},{"key":"3879_CR27","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.3748\/wjg.v16.i18.2202]","volume":"16","author":"LV McFarland","year":"2010","unstructured":"McFarland LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroentero. 2010;16:2202\u201322. [PMID: 20458757 https:\/\/doi.org\/10.3748\/wjg.v16.i18.2202]]","journal-title":"World J Gastroentero"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03879-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03879-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03879-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T16:32:32Z","timestamp":1744993952000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03879-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3879"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03879-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"PRISMA 2009 checklist statement"}}],"article-number":"273"}}